| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |